CLL, REFRACTORY
Clinical trials for CLL, REFRACTORY explained in plain language.
Never miss a new study
Get alerted when new CLL, REFRACTORY trials appear
Sign up with your email to follow new studies for CLL, REFRACTORY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cholesterol drug shows promise in leukemia combo trial
Disease control CompletedThis early-phase study tested adding the cholesterol-lowering drug pitavastatin to the standard targeted therapy venetoclax for people with chronic lymphocytic leukemia (CLL) or acute myeloid leukemia (AML). The main goal was to find a safe dose and check for side effects. Only 6…
Matched conditions: CLL, REFRACTORY
Phase: PHASE1 • Sponsor: University of California, Irvine • Aim: Disease control
Last updated May 06, 2026 16:01 UTC
-
What happens when CLL drugs stop working? new study investigates
Knowledge-focused CompletedThis study looked at 152 adults with chronic lymphocytic leukemia (CLL) whose cancer stopped responding to targeted drugs like ibrutinib and venetoclax. Researchers collected data on which treatments were used next and how well they worked. The goal was to understand the best way…
Matched conditions: CLL, REFRACTORY
Sponsor: French Innovative Leukemia Organisation • Aim: Knowledge-focused
Last updated May 17, 2026 19:11 UTC